Table 1.

Baseline patient characteristics

	Diprospan group (n = 30)	Placebo group (n = 30)	Control group (n = 30)	P value*
Male/Female, n	26/4	24/6	27/3	NS
Age, yr (mean ± SD)	67.0 ± 8.98	67.7 ± 9.2	66.4 ± 9.9	NS
Smokers/nonsmokers, n	24/6	26/4	20/10	NS
FEV1,, % (mean ± SD)	60.6 ± 9.5	62.6 ± 8.0	88.6 ± 7.1	0.001
LVEF, % (mean ± SD)	46.1 ± 12.4	46.1 ± 11.8	47.8 ± 10.3	NS
ASA class, n
2	0	0	2
3	16	21	23
4	14	9	5	0.04

*Between COPD groups (treatment+placebo) and controls.